Reuters -- Advisors to European regulators recommended Zeltia's Yondelis drug for use in the treatment of ovarian cancer, sending shares in the Spanish pharmaceutical firm sharply higher.
Reuters -- Advisors to European regulators recommended Zeltia's Yondelis drug for use in the treatment of ovarian cancer, sending shares in the Spanish pharmaceutical firm sharply higher.
